SCOTUS petition on HIV drug patents poses reputational as well as legal risks for pharma companies

SCOTUS petition on HIV drug patents poses reputational as well as legal risks for pharma companies

An HIV/AIDS non-profit organisation is seeking a change in the law surrounding patent invalidity lawsuits.

Unlock unlimited access to all IAM content